Pharmafield - COVID-19: Pharma on the Frontline
"Mental Health UK has seen an exponential increase in requests for help since COVID-19, and we hope our funding will help ensure people have continued access to the support they need"
Business Unit Director and CSR Sponsor
COVID-19 has put an enormous strain on people’s mental health. Over the last three months, almost half a million people turned to Mental Health UK and its partner charities for support. In response to this, Johnson & Johnson has made additional funding available to help stabilise and grow this critical resource. The Mental Health UK helplines support 10,000 people per year, providing information and advice on what local support is available to them, and how to access it.
The funding is an extension of a three-year partnership between Johnson & Johnson and Mental Health UK. Johnson & Johnson’s pharmaceutical arm, Janssen, has a strong heritage in mental health.
Paul Saunders, Business Unit Director, Immunology & Neuroscience & CSR Lead, Janssen UK, said, “Mental Health UK has seen an exponential increase in requests for help since COVID-19. We hope our funding will help ensure people have continued access to the support they need. There has never been a more important time to look after our own mental health, and to offer our support to those who need it most.”
This was originally published in Pf Magazine, August 2020
Job Code: EM-39255 Date of preparation: August 2020